KR950700281A - 퀴놀론카르복실산 유도체 수화물 결정(crystal of quinolonecarboxylic acid derivative hydrate) - Google Patents

퀴놀론카르복실산 유도체 수화물 결정(crystal of quinolonecarboxylic acid derivative hydrate)

Info

Publication number
KR950700281A
KR950700281A KR1019940702628A KR19940702628A KR950700281A KR 950700281 A KR950700281 A KR 950700281A KR 1019940702628 A KR1019940702628 A KR 1019940702628A KR 19940702628 A KR19940702628 A KR 19940702628A KR 950700281 A KR950700281 A KR 950700281A
Authority
KR
South Korea
Prior art keywords
crystal
acid derivative
quinolonecarboxylic acid
hydrate
derivative hydrate
Prior art date
Application number
KR1019940702628A
Other languages
English (en)
Other versions
KR100228572B1 (ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR950700281A publication Critical patent/KR950700281A/ko
Application granted granted Critical
Publication of KR100228572B1 publication Critical patent/KR100228572B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
KR1019940702628A 1992-01-31 1993-01-29 퀴놀론카르복실산 유도체 수화물 결정 KR100228572B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP1654592 1992-01-31
JP92-16545 1992-01-31
PCT/JP1993/000109 WO1993015070A1 (en) 1992-01-31 1993-01-29 Crystal of quinolonecarboxylic acid derivative hydrate

Publications (2)

Publication Number Publication Date
KR950700281A true KR950700281A (ko) 1995-01-16
KR100228572B1 KR100228572B1 (ko) 1999-11-01

Family

ID=11919237

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940702628A KR100228572B1 (ko) 1992-01-31 1993-01-29 퀴놀론카르복실산 유도체 수화물 결정

Country Status (8)

Country Link
US (1) US5597923A (ko)
EP (1) EP0629621B1 (ko)
KR (1) KR100228572B1 (ko)
AT (1) ATE207479T1 (ko)
CA (1) CA2128601C (ko)
DE (1) DE69331003T2 (ko)
ES (1) ES2167329T3 (ko)
WO (1) WO1993015070A1 (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994008967A1 (en) * 1992-10-09 1994-04-28 Chugai Seiyaku Kabushiki Kaisha Fluoroquinoline derivative
BR9509688A (pt) * 1994-11-18 1997-09-30 Upjohn Co Composto e composição farmacêutica
JP3449658B2 (ja) * 1994-12-21 2003-09-22 杏林製薬株式会社 安定性に優れた８−アルコキシキノロンカルボン酸水和物並びにその製造方法
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
GB0026490D0 (en) * 2000-10-30 2000-12-13 Pfizer Ltd Process
US7423153B2 (en) 2002-05-10 2008-09-09 Teva Pharmaceutical Industries Ltd. Crystalline forms of gatifloxacin
JP2005534633A (ja) * 2002-05-10 2005-11-17 テバ ファーマシューティカル インダストリーズ リミティド ガチフロキサシンの新規結晶形
EP1645274A1 (en) * 2002-05-10 2006-04-12 Teva Pharmaceutical Industries Ltd. Process for making gatifloxacin form omega
WO2003105851A1 (en) 2002-06-01 2003-12-24 Teva Pharmaceuticals Industries Ltd. Novel crystalline forms of gatifloxacin
US7396839B2 (en) 2002-08-06 2008-07-08 Teva Pharmaceuticals Usa, Inc. Crystalline forms of gatifloxacin
US20060264635A1 (en) * 2003-08-05 2006-11-23 Chava Satyanarayana Process for the preparation of moxifloxacin hydrochloride
US7781585B2 (en) 2004-06-04 2010-08-24 Matrix Laboratories Ltd Crystalline forms of Gatifloxacin
US7594151B2 (en) * 2004-06-18 2009-09-22 Qualcomm, Incorporated Reverse link power control in an orthogonal system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4822801A (en) * 1984-07-20 1989-04-18 Warner-Lambert Company 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents
JPH089597B2 (ja) * 1986-01-21 1996-01-31 杏林製薬株式会社 選択毒性に優れた８‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法
JPS63198664A (ja) * 1986-03-31 1988-08-17 Sankyo Co Ltd キノロンカルボン酸誘導体
JPS6490184A (en) * 1987-09-30 1989-04-06 Sankyo Co Pyridonecarboxylic acids
ATE117685T1 (de) * 1988-05-19 1995-02-15 Chugai Pharmaceutical Co Ltd Chinoloncarbonsäure-derivate.

Also Published As

Publication number Publication date
DE69331003T2 (de) 2002-06-20
DE69331003D1 (de) 2001-11-29
EP0629621A4 (en) 1995-02-01
WO1993015070A1 (en) 1993-08-05
CA2128601A1 (en) 1993-08-05
US5597923A (en) 1997-01-28
EP0629621B1 (en) 2001-10-24
ATE207479T1 (de) 2001-11-15
KR100228572B1 (ko) 1999-11-01
EP0629621A1 (en) 1994-12-21
ES2167329T3 (es) 2002-05-16
CA2128601C (en) 2003-07-15

Similar Documents

Publication Publication Date Title
ES2173982T3 (es) Hidrato de acido 8 - alcoxiquinoloncarboxilico con una estabilidad excelente y procedimiento para producir el mismo.
DE69123124D1 (de) Dihydro-Isoquinolinderivate
KR950700281A (ko) 퀴놀론카르복실산 유도체 수화물 결정(crystal of quinolonecarboxylic acid derivative hydrate)
ATE175671T1 (de) Heterocyclylcarbonylsubstituierte benzofuranyl- und -thiophenylalkancarbonsäurederivate
FI942077A (fi) Monomeerisiä sappihappojohdannaisia, menetelmä niiden valmistamiseksi ja näiden yhdisteiden käyttö lääkeaineina
FI942075A (fi) Sappihappojohdannaisten tetratsolijohdannaisia, menetelmä niiden valmistamiseksi ja näiden yhdisteiden käyttö lääkeaineina
ID27178A (id) Senyawa aminosikloheksil eter dan penggunaannya
FI905983A (fi) Aminosyraderivat.
FI892603A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten 4-(kinolin-2-yylimetoksi)fenyylietikkahappojohdannaisten valmistamiseksi
DE69132329T2 (de) Pyridazinonderivat
DE3777735D1 (de) Imid-derivate, ihre herstellung und ihre verwendung.
NO305973B1 (no) Anvendelse av quinolin og quinazolinderivater, forbindelsene som sådanne samt antiinflammatoriske midler inneholdende forbindelsene
AU5314894A (en) Novel derivatives of quinolonecarboxylic acid and naphthyridonecarboxylic acid
DE3882895T2 (de) Imid-Derivate, ihre Herstellung und Verwendung.
ES2091958T3 (es) Quinolinas 2-sustituidas, procedimiento para su obtencion asi como su uso en medicamentos.
DE58905079D1 (de) Neue alpha-aminocarbonsaeure-derivate, ihre herstellung und verwendung.
ATE160146T1 (de) Hetero-tricyclisch-substituierte phenyl- cyclohexan-carbonsäurederivate
DE69511449T2 (de) Octahydro-2-Naphthalincarbonsäure-Derivate, ihre Herstellung und Verwendung
AR023709A1 (es) Semihidrocloruro del acido 8-ciano-1-ciclopropil-7-(1s, 6s-2,8-diazabiciclo[4.3.0]-nonan-8-il)-6-fluor-1,4-dihidro-4-oxo-3-quinolincarboxilico, procedimiento para su obtencion, medicamento, empleo de los mismos para la obtencion de medicamentos antibacterianos
FI922482A (fi) Foerfarande foer framstaellning av kinolinfoerening.

Legal Events

Date Code Title Description
A201 Request for examination
N231 Notification of change of applicant
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130710

Year of fee payment: 15

FPAY Annual fee payment

Payment date: 20140704

Year of fee payment: 16

EXPY Expiration of term